2Langer CJ,Manola J,Bernardo P,et al.Cisplation-based therapy for elderly patients with advanced non-small cell lung cancer:imphcations of eastern cooperative oncelogy group 5592,a randomizedtrial.J Nail cancer Inst,2002,94(3):173～178. 被引量：1
3Curran MP,Plosker GL,et al.Vinorelbine:a review of its use in eldedy patients with advanced non-small cell lung cancer.Drugs Aging.2002,19(9):695～721. 被引量：1
5Fidias P,Supko JG,Martins R,et al.A phase Ⅱ study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer.Clin Cancer Res,2001,7(12):3942～3949. 被引量：1
2Spiro SG, Porter JC. Lung cancer-where are we today?Current advances in staging and nonsurgical treatment[J]. Am J Respir Crit Care Med, 2002, 166(9): 1166. 被引量：1
3Langer CJ, Manola J, Bernardo P, et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of eastern cooperative oncology group 5592, a randomized trial[J]. J Natl Cancer Inst,2002, 94(3): 173. 被引量：1
5Clegg A, Scott DA, Hewitson P, et al. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review[J]. Thorax, 2002, 57(1): 20. 被引量：1
